Bionime Corporation 4737

TWSE · Taiwan · Health Technology

TWD 55.400.00 (0.00%)

Market closed· Oct 1, 2026, 5:30 AM UTC· TWD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Bionime Corporation 4737

TWSE · Taiwan · Health Technology

TWD 55.400.00 (0.00%)

Market closed· Oct 1, 2026, 5:30 AM UTC· TWD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-22.73% · 6MFull-screen chart

Open TWD 55.30High TWD 56.10Low TWD 55.00Close TWD 55.40Volume 38.00K

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: TWD 55.40
Day range: TWD 55.00 – TWD 56.10
52-week range: TWD 49.75 – TWD 72.90
Volume: 38.65K
Market cap: TWD 4.17B
Next earnings date: 2026-11-06
Avg. volume (1Y): 142.06K

Performance

1 week

-1.60%

1 month

-3.65%

3 months

-2.29%

6 months

-21.97%

Year to date

-4.38%

1 year

-12.76%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Medical Specialties
Country: Taiwan
Exchange: TWSE
Shares outstanding: 77.33M
ISIN: TW0004737002
Beta: -0.04

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceJul 14, 2026

Global Blood Glucose Monitoring System Market Size to Reach USD 39.4 Billion by 2035 | Growing at 8.9% CAGR | Industry Trends, Market Share & Forecast – Custom Market Insights

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Blood Glucose Monitoring System Market size & share revenue was valued at approximately USD 16.8 Billion in 2025 and is expected to reach USD 18.3 Billion in 2026 and is expected to reach around USD 39.4 Billion by 2035, at a CAGR of 8.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Insulet Corporati

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.